Dyslipidemia in patients with chronic and end-stage kidney disease.
In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.
Jad
J
Omran
Ashraf
A
Al-Dadah
Kevin C
KC
Dellsperger
Chronic kidney disease; Dyslipidemia; End-stage renal disease; Oxidized low-density lipoprotein